Possible/JJ
differences/NNS
in/IN
the/DT
mechanism/NN
(/(
s/NNS
)/)
of/IN
action/NN
of/IN
different/JJ
glucocorticoid/NN
hormone/NN
compounds/NNS
./.

Different/JJ
glucocorticoid/NN
hormones/NNS
(/(
GCH/NN
)/)
show/VBP
differences/NNS
in/IN
the/DT
intensity/NN
and/CC
in/IN
the/DT
kinetics/NNS
of/IN
their/PRP$
immunomodulating/JJ
activity/NN
./.
=====
The/DT
mechanism/NN
(/(
s/NNS
)/)
of/IN
action/NN
of/IN
GCH/NN
is/VBZ
under/IN
investigation/NN
,/,
but/CC
is/VBZ
has/VBZ
been/VBN
noted/VBN
that/IN
they/PRP
exert/VBP
immune/JJ
activity/NN
via/IN
the/DT
genomic/JJ
pathway/NN
./.
=====
We/PRP
have/VBP
studied/VBN
the/DT
effects/NNS
of/IN
prednisone/NN
(/(
PDN/NN
)/)
,/,
deflazacort/NN
(/(
DFC/NN
)/)
,/,
and/CC
dexamethasone/NN
(/(
DXM/NN
)/)
on/IN
the/DT
production/NN
of/IN
cytokines/NNS
(/(
IL-2/NN
,/,
IL-6/NN
,/,
TNF-alpha/NN
,/,
IL-10/NN
)/)
by/IN
peripheral/JJ
T/NN
lymphocytes/NNS
,/,
and/CC
the/DT
effects/NNS
on/IN
the/DT
inhibition/NN
of/IN
NF-kB/NN
DNA/NN
binding/NN
activity/NN
by/IN
activated/JJ
Jurkat/NN
cell/NN
line/NN
./.
=====
The/DT
data/NNS
obtained/VBN
show/VBP
that/IN
the/DT
three/CD
GCH/NN
molecules/NNS
exert/VBP
an/DT
immunosuppression/NN
on/IN
cytokine/NN
production/NN
by/IN
T/NN
lymphocytes/NNS
and/CC
a/DT
strong/JJ
decrease/NN
in/IN
the/DT
nuclear/JJ
translocation/NN
of/IN
NF-kB/NN
in/IN
Jurkat/NN
cells/NNS
;/:
moreover/RB
,/,
(/(
a/LS
)/)
not/RB
all/PDT
the/DT
cytokines/NNS
investigated/VBN
were/VBD
affected/VBN
,/,
and/CC
not/RB
with/IN
the/DT
same/JJ
intensity/NN
,/,
by/IN
the/DT
three/CD
GCH/NN
and/CC
(/(
b/LS
)/)
DXM/NN
inhibited/VBD
the/DT
binding/VBG
activity/NN
of/IN
NF-kB/NN
less/CC
than/IN
that/DT
of/IN
DFC/NN
and/CC
PDN/NN
./.
=====
These/DT
data/NNS
are/VBP
in/IN
agreement/NN
with/IN
the/DT
concept/NN
that/IN
different/JJ
GCH/NN
compounds/NNS
might/MD
differ/VB
in/IN
their/PRP$
binding/NN
and/CC
affinity/NN
properties/NNS
,/,
tissue-specific/JJ
metabolism/NN
,/,
and/CC
interaction/NN
with/IN
transcription/NN
factor/NN
./.